(2R,4R)-APDC - CAS 169209-63-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
(2R,4R)-APDC is a selective and relatively potent group II mGluR agonist (EC50 = 0.4, 0.4, > 100, > 100, > 300 and > 300 μM for human mGlu2, mGlu3, mGlu1, mGlu5, mGlu4 and mGlu7 receptors, respectively). (2R,4R)-APDC is centrally active following systemic administration in vivo.
Brife Description:
group II mGluR agonist
≥98% by HPLC
Canonical SMILES:
1.The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors.
Ossowska K;Konieczny J;Pilc A;Wolfarth S Brain Res. 2002 Sep 20;950(1-2):88-94.
The aim of the present study was to find out whether the metabotropic receptor 1 (mGluR1) and group II mGluRs, localized in the striatum, are involved in antiparkinsonian-like effects in rats. Haloperidol (1 mg/kg ip) induced parkinsonian-like muscle rigidity, measured as an increased resistance of a rat's hind foot to passive flexion and extension at the ankle joint. (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA; 0.5-15 microg/0.5 microl), a potent and selective mGluR1 antagonist, or (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC; 7.5-15 microg/0.5 microl), a selective group II agonist, was injected bilaterally into the striatum of haloperidol-treated animals. AIDA in doses of 7.5-15 microg/0.5 microl diminished the haloperidol-induced muscle rigidity. In contrast, 2R,4R-APDC injections were ineffective. The present results may suggest that the blockade of striatal mGluR1, but not the stimulation of group II mGluRs, may ameliorate parkinsonian muscle rigidity.
2.Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses.
Sung KW;Choi S;Lovinger DM J Neurophysiol. 2001 Nov;86(5):2405-12.
Activation of metabotropic glutamate receptors (mGluRs), which are coupled to G proteins, has important roles in certain forms of synaptic plasticity including corticostriatal long-term depression (LTD). In the present study, extracellular field potential and whole cell voltage-clamp recording techniques were used to investigate the effect of mGluR antagonists with different subtype specificity on high-frequency stimulation (HFS)-induced LTD of synaptic transmission in the striatum of brain slices obtained from 15-to 25-day-old rats. Induction of LTD was prevented during exposure to the nonselective mGluR antagonist (RS)-alpha-methyl-4-carboxyphenylglycine (500 microM). The group I mGluR-selective antagonists (S)-4-carboxy-phenylglycine (50 microM) and (RS)-1-aminoindan-1,5-dicarboxylic acid (100 microM) prevented induction of LTD when applied before and during HFS. The mGluR1-selective antagonist 7-(Hydroxyimino) cyclopropa[b]chromen-1a-carboxylate ethyl ester (80 microM) also blocked LTD induction. Unexpectedly, the mGluR5-selective antagonist 2-methyl-6-(phenylethyl)-pyridine (10 microM) also prevented LTD induction. The group II mGluR antagonist LY307452 (10 microM) did not block LTD induction at corticostriatal synapses, but LY307452 was able to block transient synaptic depression induced by the group II agonist LY314593.
3.1-amino-APDC, a partial agonist of group II metabotropic glutamate receptors with neuroprotective properties.
Kozikowski AP;Araldi GL;Tückmantel W;Pshenichkin S;Surina E;Wroblewski JT Bioorg Med Chem Lett. 1999 Jun 21;9(12):1721-6.
The synthesis of the 1-amino derivative of (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid (1-amino-APDC), a selective metabotropic glutamate ligand, is disclosed. This compound acts as a partial agonist of the group II mGluRs and shows pronounced neuroprotective properties in the NMDA model of cell toxicity.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mGluR Products

CAS 407-41-0 O-Phospho-L-serine

(CAS: 407-41-0)

O-Phospho-L-serine, a molecule which resembles phosphatidylserine head group, is an agonist of the group III metabotropic glutamate receptors mGluR4a and mGluR6...

CAS 150145-89-4 (S)-MCPG

(CAS: 150145-89-4)

(S)-MCPG, the active isomer of (RS)-MCPG, is a non-selective group I/group II mGluR antagonist.

CAS 103439-17-4 Z-Cyclopentyl-AP4

(CAS: 103439-17-4)

Z-Cyclopentyl-AP4 is a group III mGlu receptor agonist with higher potency at mGlu4 than mGlu8 (EC50 = 49 and 124 μM, respectively). Z-Cyclopentyl-AP4 selective...

CAS 299900-84-8 YM 202074

YM 202074
(CAS: 299900-84-8)

YM 202074 is a high affinity and selective metabotropic glutamate receptor type 1 (mGlu1) antagonist. YM 202074 binds to an allosteric site of the rat mGlu1 rec...

CAS 934282-55-0 AZD 2066

AZD 2066
(CAS: 934282-55-0)

AZD 2066 is a mGluR5 anatagonist. It displays discriminative effects in rats. It is brain penetrant and orally bioavailable. It is used to prevent and treat pai...

CAS 201730-11-2 DCPG

(CAS: 201730-11-2)

DCPG is a potent and selective mGlu8a agonist (EC50 = 31 nM) displaying > 100-fold selectivity over mGlu1-7. It increases c-Fos expression in stress-related bra...

CAS 168560-79-0 AIDA

(CAS: 168560-79-0)

AIDA is a selective group I mGluR agonist and could show centrally active following systemic administration in vivo.

CAS 85148-82-9 (S)-4-Carboxy-3-hydroxyphenylglycine

(CAS: 85148-82-9)

(S)-4C3H-PG has been found to be a competitive GluR1 glutamate receptor antagonist as well as metabotropic GluR2/3 glutamate receptor agonist.

Chemical Structure

CAS 169209-63-6 (2R,4R)-APDC

Quick Inquiry

Verification code

Featured Items